Ramiro Sanchez, Chief Medical Officer at Cerevel Therapeutics Holdings, Inc. (CERE), sold 20,304 shares at $41.42 ($841K) on 2023-12-20, disclosed to the SEC on 2023-12-21.
Open-market sale of $841k CERE by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.42 | 10,152 | $420K | 50.0% |
| 2 | $41.42 | 10,152 | $420K | 50.0% |
| Total | $41.42 avg | 20,304 | $841K | 100% |
| Filing → |
| CERE | SELL | 2023-12-11 | $414K | — | Filing → |